{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:43Z","timestamp":1793157943204,"version":"4.5.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["IP.2008.31100.001"],"award-info":[{"award-number":["IP.2008.31100.001"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish International development cooperation"},{"name":"Austrian Federal Ministry of Science and Research"},{"DOI":"10.13039\/100009099","name":"Irish Aid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK NIHR"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0208328","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T18:41:50Z","timestamp":1544640110000},"page":"e0208328","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":71,"title":["First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5104-3946","authenticated-orcid":true,"given":"Alfred B.","family":"Tiono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"N\u00e9bi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Anagnostou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aboubacar S.","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Bowyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith C.","family":"Bougouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Baptist B.","family":"Yaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00efssata","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Rampling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Bliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amidou","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egeruan Babatunde","family":"Imoukhuede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9827-9836","authenticated-orcid":true,"given":"Katie J.","family":"Ewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola K.","family":"Viebig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amidou","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bejon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V. S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodiomon B.","family":"Sirima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"key":"ref1","unstructured":"WHO (2017) World Malaria Report 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/appswhoint\/iris\/bitstream\/10665\/259492\/1\/9789241565523-engpdf:196\" xlink:type=\"simple\">http:\/\/appswhoint\/iris\/bitstream\/10665\/259492\/1\/9789241565523-engpdf:196<\/ext-link>."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature24059","article-title":"The prevalence of Plasmodium falciparum in sub-Saharan Africa since 1900","volume":"550","author":"RW Snow","year":"2017","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0140-6736(10)61551-6","article-title":"Malaria elimination: worthy, challenging, and just possible","volume":"376","author":"P Das","year":"2010","journal-title":"The Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(13)62238-2","article-title":"Malaria vaccine technology roadmap","volume":"382","author":"VS Moorthy","year":"2013","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(15)00807-7","article-title":"Implementation of the malaria candidate vaccine RTS,S\/AS01","volume":"387","author":"B Greenwood","year":"2016","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1080\/14760584.2016.1236689","article-title":"The RTS,S\/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination","volume":"15","author":"P Vandoolaeghe","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"ref7","unstructured":"WHO (2018) Q&amp;A on the malaria vaccine implementation programme (MVIP). WHO."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","author":"KJ Ewer","year":"2013","journal-title":"Nat Commun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e0167951","DOI":"10.1371\/journal.pone.0167951","article-title":"Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal","volume":"11","author":"VA Mensah","year":"2016","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"286re285","DOI":"10.1126\/scitranslmed.aaa2373","article-title":"Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults","volume":"7","author":"C Ogwang","year":"2015","journal-title":"Sci Transl Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"286re285","DOI":"10.1126\/scitranslmed.aaa2373","article-title":"Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults","volume":"7","author":"C Ogwang","year":"2015","journal-title":"Sci Transl Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/mt.2016.83","article-title":"Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants","volume":"24","author":"MO Afolabi","year":"2016","journal-title":"Mol Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ymthe.2016.11.003","article-title":"Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants","volume":"25","author":"CM Bliss","year":"2017","journal-title":"Mol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3389\/fimmu.2017.01551","article-title":"Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial","volume":"8","author":"VA Mensah","year":"2017","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e107965","DOI":"10.1371\/journal.pone.0107965","article-title":"Plasmodium falciparum malaria in children aged 0\u20132 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP)","volume":"9","author":"DT Kangoye","year":"2014","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e86936","DOI":"10.1371\/journal.pone.0086936","article-title":"Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods","volume":"9","author":"AB Tiono","year":"2014","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CVI.00723-13","article-title":"Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors","volume":"21","author":"I Nebie","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/mt.2011.176","article-title":"Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors","volume":"19","author":"SH Sheehy","year":"2011","journal-title":"Mol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2006.03.029","article-title":"Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1\u20136 year old children in a malaria endemic area","volume":"24","author":"P Bejon","year":"2006","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jir850","article-title":"Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector","volume":"205","author":"GA O'Hara","year":"2012","journal-title":"J Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","article-title":"Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial","volume":"17","author":"MS Sissoko","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/jiu579","article-title":"Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals","volume":"211","author":"SH Hodgson","year":"2015","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1399-0039.2011.01661.x","article-title":"Association of HLA alleles with Plasmodium falciparum severity in Malian children","volume":"77","author":"KE Lyke","year":"2011","journal-title":"Tissue Antigens"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/352595a0","article-title":"Common west African HLA antigens are associated with protection from severe malaria","volume":"352","author":"AV Hill","year":"1991","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/317642","article-title":"HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections","volume":"183","author":"J May","year":"2001","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9128","article-title":"Prime and target immunization protects against liver-stage malaria in mice","volume":"10","author":"A Gola","year":"2018","journal-title":"Sci Transl Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0208328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T06:03:11Z","timestamp":1589004191000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0208328"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0208328","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,12]]}}}